Cargando…
Ligand-based targeting of c-kit using engineered γδ T cells as a strategy for treating acute myeloid leukemia
The application of immunotherapies such as chimeric antigen receptor (CAR) T therapy or bi-specific T cell engager (BiTE) therapy to manage myeloid malignancies has proven more challenging than for B-cell malignancies. This is attributed to a shortage of leukemia-specific cell-surface antigens that...
Autores principales: | Branella, Gianna M., Lee, Jasmine Y., Okalova, Jennifer, Parwani, Kiran K., Alexander, Jordan S., Arthuzo, Raquel F., Fedanov, Andrew, Yu, Bing, McCarty, David, Brown, Harrison C., Chandrakasan, Shanmuganathan, Petrich, Brian G., Doering, Christopher B., Spencer, H. Trent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679681/ https://www.ncbi.nlm.nih.gov/pubmed/38022523 http://dx.doi.org/10.3389/fimmu.2023.1294555 |
Ejemplares similares
-
Natural Receptor- and Ligand-Based Chimeric Antigen Receptors: Strategies Using Natural Ligands and Receptors for Targeted Cell Killing
por: Branella, Gianna M., et al.
Publicado: (2021) -
Non-signaling Chimeric Antigen Receptors Enhance Antigen-Directed Killing by γδ T Cells in Contrast to αβ T Cells
por: Fleischer, Lauren C., et al.
Publicado: (2020) -
Identification and targeting of protein tyrosine kinase 7 (PTK7) as an immunotherapy candidate for neuroblastoma
por: Lee, Jasmine Y., et al.
Publicado: (2023) -
Enhancing the effectiveness of γδ T cells by mRNA transfection of chimeric antigen receptors or bispecific T cell engagers
por: Becker, Scott A., et al.
Publicado: (2023) -
Characterization of Donor Variability for γδ T Cell ex vivo Expansion and Development of an Allogeneic γδ T Cell Immunotherapy
por: Burnham, Rebecca E., et al.
Publicado: (2020)